Advisory group formed to improve site engagement

By Melissa Fassbender contact

- Last updated on GMT

(Image: iStock/phototechno)
(Image: iStock/phototechno)

Related tags: Clinical trial

With 40% of sites dropping out of clinical trials, the Society for Clinical Research Sites (SCRS) has launched a clinical trial Site Advisory Group (SAG) as the industry works to improve site engagement.

SCRS announced the launch of the clinical trial Site Advisory Group (SAG) in partnership with Medidata yesterday.

The organization explained that the joint initiative seeks to engage investigative sites throughout the entirely of a clinical trial. The SAG’s goal “will be to identify opportunities to accelerate drug development and overcome operational challenges​,” SCRS said in its press release. This includes streamlining the reimbursement​ process, which has historically been an issue in the industry.

SCRS cited an ongoing research project conducted by the Clinical Trials Transformation Initiative​ (CTTI), which found payment delays result in high turnover rates among clinical investigators. According to the research, 40% of sites drop out of FDA-regulated clinical trials.

At this percentage, and with onboarding rate averages of $40,000 per new site, the issue is contributing to the increasing cost of drug development, according to CTTI’s research.

As the industry works to improve site relationships, today, the SCRS also announced a site engagement partnership with Eli Lilly & Company.

According to the organization, the partnership will allow for “significant involvement and increasing direct communication​” with the sites. 

Related news

Show more

Related products

show more

Validating The Simoa Technology

Validating The Simoa Technology

Frontage Laboratories | 01-Oct-2019 | Technical / White Paper

Frontage is the first and only laboratory to validate Quanterix’ Simoa HD1 Analyzer for performing immunoassays. Most of the advanced instruments used...

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Related suppliers

Follow us


View more